Home›Search›Blood Cancer Discovery

Blood Cancer Discovery

NLM (Medline) · United States · Est. 2020

ISSN2643-3230eISSN2643-3249

SJR Q1✓ WOS ESCI✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q178

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

4.623

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.483

Total Worksi

609

Total Citationsi

6,930

2yr Mean Citednessi

2.75

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Hematology; Oncology; Biochemistry, Genetics and Molecular Biology (miscellaneous); Cancer Research.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2020

Annual Volume~ 98 articles / year

StatusActive (last: 2026)

Total Publications609

Publisher OrgAmerican Association for Cancer Research

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

NLM (Medline)

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2643-3230 / 2643-3249

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

135

1.9k

2020

2.7k

2021

1.2k

2022

100

911

2023

123

501

2024

242

2025

118

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1

Cancer ResearchQ1

HematologyQ1

OncologyQ1

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyBiochemistry, Genetics and Molecular Biology (miscellaneous)Cancer ResearchOncology

Research Topics (OpenAlex)

Acute Myeloid Leukemia ResearchCAR-T cell therapy researchLymphoma Diagnosis and TreatmentProtein Degradation and InhibitorsChronic Lymphocytic Leukemia ResearchCancer Genomics and DiagnosticsMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsMonoclonal and Polyclonal Antibodies Research

Frequently asked questions about Blood Cancer Discovery

Is Blood Cancer Discovery a predatory journal?

PubScope has no integrity flags on record for Blood Cancer Discovery: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Blood Cancer Discovery?

Blood Cancer Discovery is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.75.

Is Blood Cancer Discovery indexed in Scopus and Web of Science?

Blood Cancer Discovery is indexed in Web of Science, Scopus.

What is the aims and scope of Blood Cancer Discovery?